Centre caps trade margins on non-scheduled cancer drugs at 30%, expects ₹2,500 crore annual savings for patients

The government expects to reduce prices of the non-scheduled cancer drugs by up to 70% through the move and help patients save ₹2,500 crore annually.
Read the full report on Hindustan Times
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Hindustan Times
- Published
- Friday, 9 October 2026, 8:20 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Hindustan Times with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

_606024124.jpg)

